Ownership

Neil Kumar - Chief Executive Officer, Director at BridgeBio Pharma, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: BBIO on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Neil Kumar - trading volume in the past year for BridgeBio Pharma, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-78.9K	100%	$27.57	-$2.18M
Net	-78.9K	-100%		-$2.18M

Holdings reported by Neil Kumar for BridgeBio Pharma, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	4.9M	$123M	$25.13	Aug 19, 2024	Direct
Common Stock	1.01M	$25.4M	$25.13	Aug 16, 2024	By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.
Common Stock	996K	$25M	$25.13	Aug 16, 2024	By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.
Restricted Stock Units	274K	$6.9M	$25.13	Aug 16, 2024	Direct	Common Stock
Stock Option (right to buy)	45.1K			Mar 12, 2024	Direct	Common Stock

Transactions reported by Neil Kumar for BridgeBio Pharma, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.